← Evidence map

ReviewTrends in cancer2026

Disarming cancer resistance: FAK as a therapeutic target.

Terrance J Haanen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

6 papers cite it

2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 41796449